Article
Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome.
Frontiers in endocrinology - 1 Jan 2024
Teixidó-Trujillo Silvia, Porrini Esteban, Menéndez-Quintanal Luis Manuel, Torres-Ramírez Armando, Fumero Cecilia, Rodríguez-Rodríguez Ana Elena
Abstract excerpt
Introduction: The pathogenesis of Post-Transplant Diabetes Mellitus (PTDM) is complex and multifactorial and it resembles that of Type-2 Diabetes Mellitus (T2DM). One risk factor specific to PTDM differentiates both entities: the use of immunosuppressive therapy. Specifically, Tacrolimus interacts with obesity and insulin resistance (IR) in accelerating the onset of PTDM. In a genotypic model of IR, the obese...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
